Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: arun gera who wrote (164506)	10/30/2020 9:48:08 AM
From: Horgad	Read Replies (1) \| Respond to of 218167

From my narrow view hiring in tech/IT looks strong and internship programs were not suspended just made remote. Some companies did take the opportunity to purge the ranks with a layoff, but only to immediately start hiring again. Agism is rampant in tech, skills go stale fast, salaries go up with seniority, and companies are always on the hunt for "new blood". Disclaimer: I have not researched the data on this subject. So this is just one tech guys view.

To: arun gera who wrote (164506)	10/30/2020 5:01:46 PM
From: TobagoJack	Respond to of 218167

Sensational Bloomberg or what? Of course the key word is in the title, “... May ...” bloomberg.com U.S. May Need France-Like Lockdowns to Beat Covid-19 Hospitalization rates haven’t yet reached the levels we saw in the spring, but the danger of an acute health crisis may be even greater. Sam Fazeli October 30, 2020, 7:00 PM GMT+8 Europe is responding to a new wave of Covid-19 outbreaks with renewed restrictions. So what is the U.S. going to do? Photogrpaher: Cyril Marcilhacy/Bloomberg Sam Fazeli is senior pharmaceuticals analyst for Bloomberg Intelligence and director of research for EMEA. Read more opinion LISTEN TO ARTICLE The coronavirus pandemic hasn’t finished with us yet. A spike in infections in recent weeks has sent new cases to records in a number of places around the world including the U.S., which already weathered two waves of outbreaks this year. And the weather is only starting to turn cold. Europeans have started taking draconian action again, despite the potential drag on their economies. France has introduced a new lockdown which is only slightly less harsh than the one it imposed in the spring. Germany has opted for lockdown-lite. So what is the U.S. going to do? Hospitalizations, which had been on the decline, are now rising again, with some health systems feeling the strain. In Wisconsin, a field hospital was opened on the state’s fairgrounds to accommodate patients, while capacity in El Paso, Texas, is so overtaxed that a county judge imposed stay-at-home orders. Elsewhere, though, and as a whole, hospitalizations are nowhere near where they were during the previous big outbreaks. As a result, there is a risk that the administration, governors and the public misinterpret the severity of this latest wave or downplay the danger beyond a few hotspots. This would be a mistake, and a good look at the data shows why. The chart below tracks hospitalizations relative to the daily count of positive cases of Covid-19 in the U.S. During the first wave – which was centered around the New York area from March 3 to June 11 – case counts led hospitalizations by about a week. That gap stretched to about two weeks during the second “Sun Belt” wave from June 11 to Sept. 14, and has now grown to an even longer three weeks in the current third wave. It also appears that the ratio of people in the hospital to the number of positive cases has fallen dramatically in the second and third wave. Here is where the risk of complacency rises. Source: Bloomberg Opinion, The Covid Tracking Project There are several ways to explain this evolution. First, it is very likely that the number of infections in the first wave were significantly undercounted. I personally know three friends who had mild Covid-19 symptoms very early in the pandemic – from loss of smell and taste to cough, a fever and feeling fatigued – but never got an official diagnosis. This was not only driven by the fact that we did not have access to routine tests and facilities at first, but also, as the case with my friends suggests, many never got checked out to begin with. Second, the latest wave is driven by younger individuals. While there is risk of severe Covid-19 and “long Covid” in this group, they have a much lower rate of hospitalizations. But they can certainly still spread the disease. Given the incubation period for the virus and the fact that many younger people are likely to be asymptomatic, we would expect many of them to pass on the infection to older members of their families without realizing it. In time, as more elderly people become sick, you’d expect to see an increase in hospitalizations. Another key difference from prior waves is our increased knowledge of Covid-19 and how to treat it. This has made us more stringent in deciding who gets hospitalized. During the first wave, clinicians had no idea what they were dealing with and outpatient settings didn’t know how to handle patients with moderate to severe illness. So the hospitalization rate was much higher. This time around, people who are being hospitalized are likely to have much more severe cases of the disease, which means a bigger strain on intensive-care units. The good news is that mortality rates are likely to be lower this time around as we already have better treatments and clinical management has evolved significantly. But hospitals may still be just as burdened, raising the prospect of delays in elective procedures and other care. This latest Covid-19 wave isn’t taking the same course as the prior ones, but it looks likely to end up with the same result or worse: an acute health crisis in hospitals. How can we avoid this? Proper mitigation tactics – masking, social distancing, hand-washing – should be standard operating procedure. But it may take more than that. In the coming winter months, we will tend to gather more indoors, where the virus has a very a good chance of being transmitted, while our immune systems will become less capable of fighting invading pathogens. A vaccine won’t be ready for broad deployment until well into 2021, assuming current clinical trials of experimental vaccine technologies work. States and local governments will likely need to put curbs on people mixing. Given the experience in Europe, lockdowns — or something very close to that — may be the only option. This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners. To contact the author of this story: Sam Fazeli at mfazeli@bloomberg.net To contact the editor responsible for this story: Beth Williams at bewilliams@bloomberg.net Before it's here, it's on the Bloomberg Terminal. LEARN MORE